Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Goodwill (2022 - 2025)

Collegium Pharmaceutical (COLL) has 4 years of Goodwill data on record, last reported at $145.9 million in Q3 2025.

  • For Q3 2025, Goodwill changed 0.02% year-over-year to $145.9 million; the TTM value through Sep 2025 reached $145.9 million, changed 0.02%, while the annual FY2024 figure was $162.3 million, 21.27% up from the prior year.
  • Goodwill reached $145.9 million in Q3 2025 per COLL's latest filing, down from $147.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $162.3 million in Q4 2024 and bottomed at $130.1 million in Q2 2022.
  • Average Goodwill over 4 years is $139.7 million, with a median of $133.9 million recorded in 2023.
  • Peak YoY movement for Goodwill: rose 21.27% in 2024, then dropped 0.02% in 2025.
  • A 4-year view of Goodwill shows it stood at $133.7 million in 2022, then increased by 0.12% to $133.9 million in 2023, then rose by 21.27% to $162.3 million in 2024, then decreased by 10.11% to $145.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $145.9 million in Q3 2025, $147.9 million in Q2 2025, and $150.8 million in Q1 2025.